European equities traded in the US as American depositary receipts were modestly higher late Thursday morning, rising 0.18% to 1,482.59 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company DBV (DBVT), which advanced 12% and 4.4% respectively. They were followed by accommodations booking site trivago (TRVG) and internet browser company Opera (OPRA), which increased 3.4% and 1.8%.
The decliners from continental Europe were led by financial services company ING (ING), which 0.6%. Also declining were oil and gas company Eni (E) and brewing company Anheuser-Busch InBev (BUD), which lost 0.5% and 0.2%.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Amarin (AMRN) and Akari Therapeutics (AKTX), which rose 4% and 1.8% respectively. Also climbing were software firm Endava (DAVA) medical device maker Smith & Nephew (SNN), which were up 2.5% and 1.1%.
The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana (NCNA) and Adaptimmune Therapeutics (ADAP), which dropped 24% and 2.9% respectively. They were followed by mining company BHP Group (BHP) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which were down 1.2% and nearly 1% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。